Clinical Trials Logo

No Evidence of Disease clinical trials

View clinical trials related to No Evidence of Disease.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03725449 Completed - Melanoma Clinical Trials

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Start date: November 3, 2018
Phase: N/A
Study type: Interventional

This trial studies an internet-based intervention for skin self-examination (SSE) in participants at increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to promote regular, thorough checks on the skin in individuals at increased risk for melanoma.

NCT ID: NCT02961790 Completed - Breast Carcinoma Clinical Trials

Oxybutynin Chloride in Managing Hot Flashes

Start date: December 9, 2016
Phase: Phase 3
Study type: Interventional

This randomized phase III trial studies how well oxybutynin chloride works in managing hot flashes in patients who are not candidates for, or not interested in hormone replacement therapy. Previous studies have shown that oxybutynin is effective in managing hot flashes, however doses used in prior studies have resulted in side effects. This trial is evaluating lower doses of oxybutynin with the goal of determining if they are efficacious with less side effects. ADAM-VTE

NCT ID: NCT02288416 Completed - Anxiety Clinical Trials

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

Start date: December 8, 2014
Phase: N/A
Study type: Interventional

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life.

NCT ID: NCT02099136 Completed - Clinical trials for No Evidence of Disease

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

Start date: September 1999
Phase: Phase 2
Study type: Interventional

This randomized clinical trial studies if celecoxib will prevent the damaging effects of sunburn in healthy volunteers. Exposure to ultraviolet light can induce erythema, sunburn or skin redness caused by inflammation. Celecoxib may reduce skin damage by blocking enzymes associated with sunburn in healthy volunteers. Studying samples of skin in the laboratory from patients receiving ultraviolet-radiation before and after celecoxib treatment may help doctors learn more about the effects celecoxib has on cells.

NCT ID: NCT02090933 Completed - Clinical trials for No Evidence of Disease

Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers

Start date: March 2004
Phase: Phase 2
Study type: Interventional

This clinical trial studies celecoxib in decreasing the damaging effects of sunburn in healthy volunteers. Celecoxib may reduce skin damage by blocking enzymes associated with sunburn in healthy volunteers.

NCT ID: NCT01698294 Completed - Clinical trials for No Evidence of Disease

Biomarkers in Post-Menopausal Women Receiving Flaxseed

Start date: December 14, 2012
Phase: N/A
Study type: Interventional

This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.

NCT ID: NCT01497431 Completed - Prostate Carcinoma Clinical Trials

Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

Start date: November 2011
Phase: Phase 1
Study type: Interventional

This randomized phase I trial studies the side effects and the best dose of Se-methyl-seleno-L-cysteine or selenomethionine in preventing prostate cancer in healthy participants. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of Se-methyl-seleno-L-cysteine or selenomethionine, two different types of selenium compounds, may prevent prostate cancer from forming.

NCT ID: NCT01149096 Completed - Clinical trials for No Evidence of Disease

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

Start date: June 14, 2010
Phase: Phase 3
Study type: Interventional

This randomized clinical trial is studying the side effects of collection of bone marrow from donors treated with or without filgrastim. Giving colony-stimulating factors, such as filgrastim (G-CSF), to donors helps the stem cells move from the bone marrow to the blood so they can be collected and stored.

NCT ID: NCT00896974 Completed - Clinical trials for No Evidence of Disease

Study of 9cUAB30 in Healthy Participants

Start date: August 2008
Phase: Phase 1
Study type: Interventional

This research study is looking at 9cUAB30 in healthy participants. Studying samples of blood and urine from healthy participants may help doctors learn more about how 9cUAB30 is used by the body.